Clincosm LogoSign in Get a demo

Solid Tumor

Showing 1 - 25 of 763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Taichung (HLA-G-CAR.BiTE allogeneic ?d T cells)

Not yet recruiting
  • Solid Tumor
  • HLA-G-CAR.BiTE allogeneic γδ T cells
  • Taichung, Non-US, Taiwan
    China Medical University Hospital
Nov 27, 2023

Solid Tumor, Gynecological Tumors Trial in Shanghai (GT316)

Recruiting
  • Solid Tumor
  • Gynecological Tumors
  • GT316
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Nov 17, 2023

Solid Tumor Trial (DR30206)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Nov 14, 2023

Gastric Cancer, Pancreatic Cancer, Solid Tumor Trial in Beijing (KD-496)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • KD-496
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 15, 2023

Solid Tumor Trial in Shanghai (WX390)

Recruiting
  • Solid Tumor
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 2, 2023

Solid Tumor Trial in Changchun (WX390, Toripalimab)

Recruiting
  • Solid Tumor
  • Changchun, Jilin, China
    the first affiliated hospital of Jilin university
Nov 3, 2023

Solid Tumor Trial in China (TQB2450 injection, AL2846 capsule, Pemetrexed disodium for injection)

Active, not recruiting
  • Solid Tumor
  • TQB2450 injection
  • +3 more
  • Beijing, Beijing, China
  • +11 more
Oct 31, 2023

Solid Tumor Trial in Shenyang (Intravenous infusion anti-HER2-CAR-T cell)

Not yet recruiting
  • Solid Tumor
  • Intravenous infusion anti-HER2-CAR-T cell
  • Shenyang, Liaoning, China
    Phase I Clinical Trials Center Of The First Hospital of China Me
Oct 30, 2023

Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

Not yet recruiting
  • Carcinoma
  • Solid Tumor
  • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 26, 2023

Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)

Not yet recruiting
  • Solid Tumor
  • Hematological Malignancy
  • Locus Health iPhone App
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Oct 24, 2023

Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +4 more
  • (no location specified)
Oct 23, 2023

Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

Recruiting
  • Refractory Cancer
  • +14 more
  • Atlanta, Georgia
  • +1 more
Oct 23, 2023

Tumor Vaccines for Solid Tumors

Recruiting
  • Glioma
  • Solid Tumor
  • tumor vaccine
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Oct 22, 2023

Solid Tumor Trial in United States (QN-302)

Not yet recruiting
  • Solid Tumor
  • Scottsdale, Arizona
  • +3 more
Oct 11, 2023

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

Recruiting
  • Cancer
  • +12 more
  • Tripoli, North Lebanon, Lebanon
  • +1 more
Oct 5, 2023

Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)

Not yet recruiting
  • Solid Tumor
  • M1-c6v1
  • Kashiwa-shi, Chiba, Japan
  • +2 more
Sep 19, 2023

Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2023

Switching H1-antagonist Clemastine to Cetirizine in

Active, not recruiting
  • Solid Tumor
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Sep 8, 2023

Solid Tumor, Cutaneous Squamous Cell Carcinoma, Endometrial Cancer Trial (favezelimab/pembrolizumab, pembrolizumab, lenvatinib)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • favezelimab/pembrolizumab
  • +2 more
  • (no location specified)
Sep 7, 2023

ful Mutations in Solid Tumor Characterized by Next Generation

Recruiting
  • Solid Tumor
  • +13 more
    • Aviano, Pordonone, Italy
      IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
    Sep 8, 2023

    Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)

    Recruiting
    • Solid Tumor
    • EGFR Amplification
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Aug 28, 2023

    Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

    Recruiting
    • Solid Tumor
    • +4 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Aug 28, 2023

    Solid Tumor Trial in Zhengzhou, Jinan (RC148)

    Not yet recruiting
    • Solid Tumor
    • Zhengzhou, Henan, China
    • +2 more
    Aug 24, 2023

    Solid Tumor Trial in Shanghai (DC cells)

    Recruiting
    • Solid Tumor
    • DC cells
    • Shanghai, Shanghai, China
      Shanghai Mengchao Cancer Hospital
    Aug 23, 2023